ISSN: 2578-6520
Home / Browse Journals & Books / Annals of Heart / Archive / Volume 6, Issue 1
Select All | |
Original Study Pages 170-177
Abstract: Long-term risk stratification in non-ST-elevation acute coronary syndrome (NSTE-ACS) by the ACEF score has not yet been assessed. The ACEF score (age/left ventricular ejection fraction +1 [if creatinine > 20 mg/l]) has been established in patients evaluated for coronary artery bypass surgery. This is a prospective observational study, including 196 NSTE-ACS patients with invasive management and completing a 5-year follow-up after hospital discharge. ACEF score was calculated at admission. The primary endpoint was 5-year all-cause death. The secondary endpoint was major adverse cardiac and cerebrovascular events (MACCE).
| | |
Case Study Pages 164-169
Abstract: This hypothesis-generating, case series reviews the evidence available for managing left atrial appendage thrombus in patients already on therapeutic anticoagulation with apixaban. Our six patient cases highlight the first documented evidence of complete, accelerated clot resolution upon the addition of P2Y12 inhibitor, clopidogrel, to current therapeutic doses of apixaban.
Original Study Pages 152-163
Abstract: In particular settings, achieving complete coronary revascularization could be very challenging. The Syntax Revascularization Index (SRI) represents a useful tool to assess the degree of coronary revascularization in patients undergoing percutaneous coronary intervention (PCI). This study aimed to assess the prognostic usefulness of the SRI in an “all comers” cohort of patients undergoing PCI.
Original Study Pages 146-151
Abstract: The aim of this study was to compare an early versus a delayed invasive strategy in NSTE-ACS prospectively. Prospective observational study including patients admitted for NSTE-ACS requiring an invasive management. The primary endpoint was the occurrence of MACCE (death, new myocardial infarction or stroke) at 30-days and 1-year follow-up.
Track your Manuscript Status